Actively Recruiting

Age: 18Years - 100Years
All Genders
ID07045753

A Prospective Follow-up Assessment in Bad Segeberg With Patients With Severe Mitral Regurgitation Undergoing Mitral Edge-to-edge Repair (M-TEER)

Led by Segeberger Kliniken GmbH · Updated on 2025-07-01

2000

Participants Needed

1

Research Sites

104 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This research aims to follow patients with severe mitral regurgitation (MR) who are treated using a procedure called mitral edge-to-edge repair (M-TEER). The study is conducted at a single center, the Heart Center in Bad Segeberg, Germany, and focuses on observing patients undergoing this treatment to understand their health outcomes over time. Participants receive the mitral valve transcatheter edge-to-edge repair (M-TEER), a device-based procedure designed to address severe MR. The study records data from patients treated with this procedure and follows them through a routine clinical schedule, including long-term follow-up to monitor their condition and treatment effects. Throughout the study, participants undergo regular clinical assessments, with researchers tracking their health status and any cardiovascular adverse events that occur both during hospitalization and over a two-year period. The main outcome measured is the rate of these adverse events. Participants are monitored closely according to the study protocol, which extends over a long-term timeline to gather comprehensive follow-up information.

CONDITIONS

Brief Title

The Prospective Segeberg Registry for Mitral Transcatheter Edge-to-Edge Repair

Who Can Participate

Age: 18Years - 100Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients with severe MR undergoing M-TEER
Not Eligible

You will not qualify if you...

History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Implementation

Duration - Day of procedure

Participants undergo mitral valve transcatheter edge-to-edge repair (M-TEER).

1 visit (in-person)

Post-operative Follow-up

Duration - Up to 2 years

Participants are observed through routine clinical follow-up including long-term assessments after the repair procedure.

Routine clinical follow-up visits as per standard care

Trial Site Locations

Total: 1 location

1

Herzzentrum Segeberger Kliniken GmbH

Bad Segeberg, Schleswig-Holstein, Germany, 23795

Actively Recruiting

Loading map...

Research Team

A

Arief Kurniadi, MD

S

Stephan Fichtlscherer, Prof., MD

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Similar Trials

Deep Learning for Echo Analysis, Tracking, and Evaluation Pr...

Valve Disease, Aortic

Actively Recruiting

1 location

MItral Regurgitation Risk Assessment and CLinical modElling ...

Mitral Insufficiency

Actively Recruiting

1 location

Safety and Feasibility Study of the MitraFix4 Transcatheter...

Mitral Regurgitation (MR)

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here